Bioaccelerate Holdings

Web Sites

Bioaccelerate Hldgs (BACL) News - Company News and Press Releases

Track Any Stock Instantly Just enter up to ten of your stocks in the Stock Tracker box, click the ADD button beside any of Today's Hot Stocks, or click ADD beside any of the stocks you've Recently Viewed.

http://www.investorguide.com/stock-news.cgi?ticker=BACL

Pharmacy Choice - Pharmaceutical News - Bioaccelerate Holdings Inc. and Symbollon Pharmaceuticals,

Under terms of the agreement, Bioaccelerate will fund ongoing Phase III development of IoGen through its wholly owned subsidiary, Amilar Pharmaceuticals, a specialty pharmaceutical company with development stage compounds in women's health.

http://www.pharmacychoice.com/News/article.cfm?Article_ID=1270

Biosaxony

Under the terms of the agreement Bioaccelerate will fund the further development of the portfolio through to commercialisation. The agreement will leverage both parties extensive experience in Oncology development with Faustus utilising their facilities for the development work.

http://www.biosaxony.de/e_sites/artikel.php?id=175

Newport Pharmaceuticals Ltd. Announces Update on Co-Development Program For Isoprinosine For

Newport Pharmaceuticals Ltd. Announces Update on Co-Development Program For Isoprinosine For Chronic Fatigue Syndrome ImmuneSupport.com 10-31-2005 Source: Bioaccelerate, Inc. Newport Pharmaceuticals Ltd. Announces Update on Co-Development Program For Isoprinosine DUBLIN, Ireland, Oct.

http://www.immunesupport.com/library/showarticle.cfm/ID/6797